Table 1 Characteristics of the community-acquired pneumonia population (n = 96), according to the presence of cancer
Characteristic | Cancer | p-value | |||
|---|---|---|---|---|---|
| Â | No (n = 77) | Yes (n = 19) | Â | ||
| Â | Median (IQR) | Patients n (%) | Median (IQR) | Patients n (%) | Â |
Age (years) | 60 (43–72) |  | 60 (39–72) |  | 0.956 |
Gender (male) | Â | 45 (58.4) | Â | 11 (57.9) | 1.000 |
Co-morbidities | Â | Â | Â | Â | Â |
   Chronic lung disease |  | 19 (24.7) |  | 1 (5.3) | 0.110 |
   Heart disease |  | 21 (27.3) |  | 2 (10.5) | 0.147 |
   Chronic kidney disease |  | 10 (13.0) |  | 4 (21.1) | 0.467 |
   Chronic liver disease |  | 8 (10.4) |  | 0 (0.0) | 0.350 |
   Diabetes mellitus |  | 10 (12.0) |  | 1 (5.3) | 0.687 |
   HIV infection |  | 6 (7.8) |  | 0 (0.0) | 0.595 |
Days before ICU admission | 1 (0–3) |  | 2 (1–5) |  | 0.049 |
Severity on admission to ICU | Â | Â | Â | Â | Â |
   APACHE II | 20 (14–24) |  | 25 (20–29) |  | 0.009 |
   SAPS II | 43 (34–53) |  | 51 (42–62) |  | 0.039 |
   SOFA | 9 (4–12) |  | 12 (10–13) |  | 0.018 |
Organ support during ICU admission | Â | Â | Â | Â | Â |
   Duration of MV (days) | 5 (1–15) |  | 4 (2–25) |  | 0.530 |
   MV |  | 65 (84.4) |  | 17 (89.5) | 0.729 |
      Invasive |  | 58 (75.3) |  | 16 (84.2) | 0.708 |
      Non-invasive |  | 7 (9.1) |  | 1 (5.3) |  |
   Renal replacement therapy |  | 24 (31.2) |  | 7 (36.8) | 0.785 |
Inotropes/vasopressors during ICU admission | Â | 49 (63.6) | Â | 17 (89.5) | 0.030 |